Lois Coulter Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
faculty
Research Areas
Biography and Research Information
OverviewAI-generated summary
Lois Coulter's research has focused on interventions and health outcomes within community pharmacy settings. She has published on the efficacy of cranberry extract for preventing recurrent urinary tract infections (rUTIs) in adult women and the use of topical vaginal estrogens in postmenopausal women to prevent rUTIs. Her work also includes an investigation into whether rifaximin decreases small intestinal bacterial overgrowth in patients diagnosed with irritable bowel syndrome. Coulter's scholarship metrics include an h-index of 3, with 43 total publications and 36 total citations. She has collaborated with Jonell Hudson and Katharine Darland, both affiliated with the University of Arkansas for Medical Sciences, on multiple shared publications.
Metrics
- h-index: 3
- Publications: 43
- Citations: 36
Selected Publications
-
Does cranberry extract taken daily by mouth prevent rUTIs in adult women (2021)
Collaboration Network
Top Collaborators
- Does cranberry extract taken daily by mouth prevent rUTIs in adult women
- Do topical vaginal estrogens help prevent rUTI in postmenopausal women?
- Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?
- Do topical vaginal estrogens help prevent rUTI in postmenopausal women?
- Do topical vaginal estrogens help prevent rUTI in postmenopausal women?
- Do topical vaginal estrogens help prevent rUTI in postmenopausal women?
- Does cranberry extract taken daily by mouth prevent rUTIs in adult women
- Does cranberry extract taken daily by mouth prevent rUTIs in adult women
- Does cranberry extract taken daily by mouth prevent rUTIs in adult women
- Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?
- Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?
- Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?
Similar Researchers
Based on overlapping research topics